Aaron S Kesselheim

InstitutionBrigham and Women's Hospital and Harvard Medical School
AddressBoston
Massachusetts
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 4 publications in Spetember 2020
    All Publications
    Bar chart showing 348 publications over 18 distinct years, with a maximum of 51 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Beall RF, Kesselheim AS, Hollis A. Premarket Development Times for Innovative Vaccines--To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers? Clin Infect Dis. 2022 01 29; 74(2):347-351. PMID: 33914860.
      Citations: 1     Fields:    
    2. Lalani HS, Avorn J, Kesselheim AS. US Taxpayers Heavily Funded the Discovery of COVID-19 Vaccines. Clin Pharmacol Ther. 2022 03; 111(3):542-544. PMID: 34243221.
      Citations: 1     Fields:    
    3. Raimond V, Mousquès J, Avorn J, Kesselheim AS. Characteristics of Clinical Trials Launched Early in the COVID-19 Pandemic in the US and in France. J Law Med Ethics. 2021; 49(1):139-151. PMID: 33966651.
      Citations:    Fields:    Translation:Humans
    4. Kesselheim AS, Darrow JJ, Kulldorff M, Brown BL, Mitra-Majumdar M, Lee CC, Moneer O, Avorn J. An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19. Health Aff (Millwood). 2021 01; 40(1):25-32. PMID: 33211535.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    5. Naci H, Kesselheim AS, Røttingen JA, Salanti G, Vandvik PO, Cipriani A. Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19. BMJ. 2020 10 16; 371:m3869. PMID: 33067179.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    6. Raunig BL, Kesselheim AS, Darrow JJ. Drug Shortages and the Defense Production Act. Am J Public Health. 2020 10; 110(10):1504-1505. PMID: 32903085.
      Citations:    Fields:    Translation:HumansPHPublic Health
    7. Avorn J, Kesselheim AS. Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval. N Engl J Med. 2020 Oct 29; 383(18):1706-1708. PMID: 32931162.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    8. Lee CC, Darrow JJ, Avorn J, Kesselheim AS. Origins and Ownership of Remdesivir: Implications for Pricing. J Law Med Ethics. 2020 09; 48(3):613-618. PMID: 33021169.
      Citations:    Fields:    Translation:Humans
    9. Tan YT, Kesselheim AS. Implementing U.S. Covid-19 Testing: Regulatory and Infrastructural Challenges. J Law Med Ethics. 2020 Sep; 48(3):606-612. PMID: 33021179.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    10. Zhai MZ, Lye CT, Kesselheim AS. Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies. JAMA Intern Med. 2020 09 01; 180(9):1145-1146. PMID: 32427277.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    11. Liu M, Caputi TL, Dredze M, Kesselheim AS, Ayers JW. Internet Searches for Unproven COVID-19 Therapies in the United States. JAMA Intern Med. 2020 08 01; 180(8):1116-1118. PMID: 32347895.
      Citations: 32     Fields:    Translation:HumansCellsPHPublic Health
    12. Sarpatwari A, Kaltenboeck A, Kesselheim AS. Missed Opportunities on Emergency Remdesivir Use. JAMA. 2020 07 28; 324(4):331-332. PMID: 32579163.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    13. Woloshin S, Patel N, Kesselheim AS. False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications. N Engl J Med. 2020 Aug 06; 383(6):e38. PMID: 32502334.
      Citations: 277     Fields:    Translation:HumansCellsPHPublic Health
    Kesselheim's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (352)
    Explore
    _
    Co-Authors (32)
    Explore
    _
    Similar People (60)
    Explore
    _